切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2025, Vol. 11 ›› Issue (01) : 76 -79. doi: 10.3877/cma.j.issn.2095-9605.2025.01.011

病例报告

单孔腹腔镜袖状胃切除术联合经颏下前庭腔镜下甲状腺癌根治术治疗肥胖合并单侧甲状腺癌1 例报道
张弘玮1, 彭刚1, 班旭彦1, 王晨1, 许听1, 刘伟杰1, 韩晓东1,()   
  1. 1. 200233 上海,上海交通大学医学院附属第六人民医院普通外科
  • 收稿日期:2024-10-18 出版日期:2025-02-28
  • 通信作者: 韩晓东

Single-port laparoscopic sleeve gastrectomy combined with transoral endoscopic thyroidectomy vestibular approach for the treatment of obesity with unilateral thyroid cancer:1 case report

Hongwei Zhang1, Gang Peng1, Xuyan Ban1, Chen Wang1, Ting Xu1, Weijie Liu1, Xiaodong Han1,()   

  1. 1. Department of General Surgery,Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200233,China
  • Received:2024-10-18 Published:2025-02-28
  • Corresponding author: Xiaodong Han
引用本文:

张弘玮, 彭刚, 班旭彦, 王晨, 许听, 刘伟杰, 韩晓东. 单孔腹腔镜袖状胃切除术联合经颏下前庭腔镜下甲状腺癌根治术治疗肥胖合并单侧甲状腺癌1 例报道[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 76-79.

Hongwei Zhang, Gang Peng, Xuyan Ban, Chen Wang, Ting Xu, Weijie Liu, Xiaodong Han. Single-port laparoscopic sleeve gastrectomy combined with transoral endoscopic thyroidectomy vestibular approach for the treatment of obesity with unilateral thyroid cancer:1 case report[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2025, 11(01): 76-79.

肥胖与甲状腺癌之间存在显著相关性,目前针对肥胖合并甲状腺癌的治疗方案的研究和文献相对有限。本文报告了1例31岁女性患者,因体检发现胰岛素抵抗及甲状腺肿瘤3 d后入院。患者体质量110 kg,BMI 38.5 kg/m²,辅助检查显示抗甲状腺过氧化物酶抗体升高,甲状腺超声提示双叶甲状腺结节,结合穿刺结果考虑甲状腺癌可能。在上海交通大学医学院附属第六人民医院减重代谢外科的多学科团队协作下,患者成功接受了单孔腹腔镜袖状胃切除术联合经颏下前庭腔镜下甲状腺癌根治术的一期手术治疗。手术时间为205 min,患者术后恢复顺利,无明显并发症。此治疗方案展现了减少多次麻醉和住院需求的优势,同时满足患者对美观和快速康复的需求,为肥胖合并甲状腺癌患者的治疗提供了新的选择。

The incidence of both obesity and thyroid cancer is rising worldwide,and obesity has become an important risk factor for thyroid cancer.Studies have shown a significant correlation between obesity and thyroid cancer; however,treatment strategies for patients with both conditions are currently under-researched.This case report describes a 31-year-old female patient admitted to the hospital after a routine check-up detected insulin resistance and a thyroid tumor three days prior.The patient had a body weight of 110 kg and a body mass index (BMI) of 38.5 kg/m².Auxiliary examinations revealed elevated antithyroid peroxidase antibody (TPOAb) levels,and thyroid ultrasound showed bilateral thyroid nodules,with a suspicion of thyroid cancer based on fine-needle aspiration results.A multidisciplinary team at the Department of Bariatric and Metabolic Surgery,Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine successfully performed a single-port laparoscopic sleeve gastrectomy combined with a transoral endoscopic thyroidectomy vestibular approach for thyroid cancer in a single-stage procedure.The surgery lasted 205 minutes,and the patient had an uneventful recovery without significant complications.This combined approach effectively reduced the need for multiple anesthesia and hospital admissions while meeting the patient's needs for cosmetic outcomes and rapid recovery,offering a novel treatment option for patients with obesity and thyroid cancer.

图1 甲状腺及袖状胃切除后的标本图
图2 单孔腹腔镜术后患者腹部切口的术后照片
图3 颏下切口处引流管的置入图片
图4 患者拆线后腹部切口
图5 患者拔管后颏下切口
图6 患者术后1月原腹部切口
图7 患者术后1月原颏下切口
[1]
Chen K,Shen Z,Gu W,et al.Prevalence of obesity and associated complications in China:A cross-sectional,real-world study in 15.8 million adults [J].Diabetes Obes Metab,2023,25(11):3390-3399.
[2]
Lim H,Devesa SS,Sosa JA,et al.Trends in thyroid cancer incidence and mortality in the United States,1974-2013 [J].Jama,2017,317(13):1338-1348.
[3]
Kitahara CM,McCullough ML,Franceschi S,et al.Anthropometric factors and thyroid cancer risk by histological subtype:pooled analysis of 22 prospective studies [J].Thyroid,2016,26(2):306-318.
[4]
Almquist M,Johansen D,Björge T,et al.Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can) [J].Cancer Causes Control,2011,22(5):743-751.
[5]
Liu C,Yuan YC,Guo MN,et al.Rising incidence of obesity-related cancers among younger adults in China:A population-based analysis(2007-2021) [J].Med,2024,5(11):1402-1412.e2.
[6]
Hou T,Li Y,Yan Q,et al.The interaction effect between BMI,diabetes and age at diabetes onset on the risk of thyroid cancer:A population-based cohort study in Shanghai,China [J].Diabetes Obes Metab,2024,26(9):3988-3997.
[7]
Kwon H,Chang Y,Cho A,et al.Metabolic obesity phenotypes and thyroid cancer risk:a cohort study [J].Thyroid,2019,29(3):349-358.
[8]
Pasqual E,O'Brien K,Rinaldi S,et al.Obesity,obesity-related metabolic conditions,and risk of thyroid cancer in women:results from a prospective cohort study (Sister Study) [J].Lancet Reg Health Am,2023,23:100537.
[9]
Matrone A,Ferrari F,Santini F,et al.Obesity as a risk factor for thyroid cancer [J].Curr Opin Endocrinol Diabetes Obes,2020,27(5):358-63.
[10]
Calle EE,Kaaks R.Overweight,obesity and cancer:epidemiological evidence and proposed mechanisms [J].Nat Rev Cancer,2004,4(8):579-591.
[11]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会,中国医师协会外科医师分会甲状腺外科医师委员会.肥胖代谢病合并甲状腺癌外科治疗专家共识(2021版) [J/CD].中华肥胖与代谢病电子杂志,2022,8(1):9-14.
[12]
中华人民共和国国家卫生健康委员会医政医管局.甲状腺癌诊疗指南(2022年版) [J].中国实用外科杂志,2022,42(12):16.
[1] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 1-8.
[2] 陆嘉杰, 严帅, 蔡卫华, 吴金柱. 肥胖症患者袖状胃切除术后体重反弹的相关因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 349-352.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 刘见, 杨晓波, 何均健, 吴淼. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[5] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
[6] 刘皖, 赵婷婷, 魏明辉. 铜绿假单胞菌注射液术区注射治疗颈淋巴结清扫术后顽固性高流量乳糜漏二例及文献复习[J/OL]. 中华临床医师杂志(电子版), 2024, 18(10): 926-930.
[7] 杨菲, 刘腾飞, 赵志军, 李睿聪, 张颉, 刘妍, 赵珍. 血清维生素水平与分化型甲状腺癌的关联性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 633-640.
[8] 张睿旻, 朱红梅, 刘雁军. 中国肥胖代谢外科临床研究现状及展望:一项计量学研究[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 1-10.
[9] 张源, 张忠洋, 谢杰斌, 梁钿苑, 余征航, 任亦星. 新型减重药物的作用机制与研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 11-18.
[10] 王文博, 曹耀权, 朱利勇. 新型减重药物的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 19-25.
[11] 李梦蝶, 王勇. 替西帕肽在优化减重代谢手术中的作用展望[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 26-32.
[12] 宋宇佳, 孟化. 基于营养刺激激素受体靶点新型减重药物的临床研究现状与进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 33-39.
[13] 汪和, 胡梦杰, 王天爱, 梅紫暄, 龚铖, 潘定宇, 李震. 新型减重药物在肥胖治疗中的应用进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 40-45.
[14] 张畅, 周昆明, 黄桢雅, 孙鸿儒, 蔺宏伟. 符合脐解剖的经脐横行小切口在单孔腹腔镜减重手术中的应用[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 46-52.
[15] 门航, 厉周, 韩帅. 肥胖与2 型糖尿病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 62-69.
阅读次数
全文


摘要